# Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons

> **NCT05382091** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Go Medical Industries Pty Ltd** · enrollment: 250 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** naltrexone implant

## Key facts

- **NCT ID:** NCT05382091
- **Lead sponsor:** Go Medical Industries Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2028-07-15
- **Final completion:** 2029-07-15
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05382091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05382091, "Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05382091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*